TELA Bio, Inc. (TELA) Operating income 2017–2025
TELA Bio, Inc. (TELA) annual operating income history from SEC filings — each fiscal year as reported.
-$33.8MFY2025 · since FY2017: -$16.9M → -$33.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.8M | +1.1% |
| FY2024 | -$34.1M | +22.6% |
| FY2023 | -$44.1M | -13.0% |
| FY2022 | -$39.0M | -32.4% |
| FY2021 | -$29.5M | -16.5% |
| FY2020 | -$25.3M | -31.9% |
| FY2019 | -$19.2M | -7.8% |
| FY2018 | -$17.8M | -5.1% |
| FY2017 | -$16.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TELA financial trends
TELA RevenueTELA Net incomeTELA Net marginTELA Gross profitTELA Gross marginTELA Operating marginTELA Operating cash flowTELA Free cash flowTELA Capital expendituresTELA Return on equityTELA Stock buybacksTELA Dividends paidTELA Total assetsTELA Total liabilitiesTELA Shareholders’ equityTELA overview →